ProCE Banner Activity

Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Slideset

Download these slides covering the latest evidence and recommendations on how to mitigate AEs secondary to CDK4/6 inhibitors and promote adherence and persistence with treatment.

Released: December 06, 2024

Expiration: December 05, 2025

Share

Faculty

Laura M. Spring

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation